nach oben

Diabetologia

Erschienen in:

01.07.2014 | Article

Doc2b enrichment enhances glucose homeostasis in mice via potentiation of insulin secretion and peripheral insulin sensitivity

verfasst von: Latha Ramalingam, Eunjin Oh, Debbie C. Thurmond

Erschienen in: Diabetologia | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Insulin secretion from pancreatic beta cells and insulin-stimulated glucose uptake into skeletal muscle are processes regulated by similar isoforms of the soluble N-ethylmaleimide-sensitive factor-attachment protein receptor (SNARE) and mammalian homologue of unc-18 (Munc18) protein families. Double C2 domain β (Doc2b), a SNARE- and Munc18-interacting protein, is implicated as a crucial effector of glycaemic control. However, whether Doc2b is naturally limiting for these processes, and whether Doc2b enrichment might exert a beneficial effect upon glycaemia in vivo, remains undetermined.

Methods

Tetracycline-repressible transgenic (Tg) mice engineered to overexpress Doc2b simultaneously in the pancreas, skeletal muscle and adipose tissues were compared with wild-type (Wt) littermate mice regarding glucose and insulin tolerance, islet function in vivo and ex vivo, and skeletal muscle GLUT4 accumulation in transverse tubule/sarcolemmal surface membranes. SNARE complex formation was further assessed using Doc2b overexpressing L6-GLUT4-myc myoblasts to derive mechanisms relatable to physiological in vivo analyses.

Results

Doc2b Tg mice cleared glucose substantially faster than Wt mice, correlated with enhancements in both phases of insulin secretion and peripheral insulin sensitivity. Heightened peripheral insulin sensitivity correlated with elevated insulin-stimulated GLUT4 vesicle accumulation in cell surface membranes of Doc2b Tg mouse skeletal muscle. Mechanistic studies demonstrated Doc2b enrichment to enhance syntaxin-4–SNARE complex formation in skeletal muscle cells.

Conclusions/interpretation

Doc2b is a limiting factor in SNARE exocytosis events pertinent to glycaemic regulation in vivo. Doc2b enrichment may provide a novel means to simultaneously boost islet and skeletal muscle function in vivo in the treatment and/or prevention of diabetes.

Nur mit Berechtigung zugänglich

Ohara-Imaizumi M, Fujiwara T, Nakamichi Y et al (2007) Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis. J Cell Biol 177:695–705PubMedCentralPubMedCrossRef

Zhu D, Koo E, Kwan E et al (2013) Syntaxin-3 regulates newcomer insulin granule exocytosis and compound fusion in pancreatic beta cells. Diabetologia 56:359–369PubMedCrossRef

Spurlin BA, Thurmond DC (2006) Syntaxin 4 facilitates biphasic glucose-stimulated insulin secretion from pancreatic beta-cells. Mol Endocrinol 20:183–193PubMedCrossRef

Regazzi R, Wollheim CB, Lang J et al (1995) VAMP-2 and cellubrevin are expressed in pancreatic beta-cells and are essential for Ca(2+)-but not for GTP gamma S-induced insulin secretion. EMBO J 14:2723–2730PubMedCentralPubMed

Sadoul K, Berger A, Niemann H et al (1997) SNAP-23 is not cleaved by botulinum neurotoxin E and can replace SNAP-25 in the process of insulin secretion. J Biol Chem 272:33023–33027PubMedCrossRef

Zhu D, Zhang Y, Lam PP et al (2012) Dual role of VAMP8 in regulating insulin exocytosis and islet beta cell growth. Cell Metab 16:238–249PubMedCrossRef

Klip A (2009) The many ways to regulate glucose transporter 4. Appl Physiol Nutr Metab 34:481–487PubMedCrossRef

Yang C, Coker KJ, Kim JK et al (2001) Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. J Clin Invest 107:1311–1318PubMedCentralPubMedCrossRef

Cheatham B, Volchuk A, Kahn CR, Wang L, Rhodes CJ, Klip A (1996) Insulin-stimulated translocation of GLUT4 glucose transporters requires SNARE-complex proteins. Proc Natl Acad Sci U S A 93:15169–15173PubMedCentralPubMedCrossRef

10.

Kawanishi M, Tamori Y, Okazawa H, Araki S, Shinoda H, Kasuga M (2000) Role of SNAP23 in insulin-induced translocation of GLUT4 in 3 T3-L1 adipocytes. Mediation of complex formation between syntaxin4 and VAMP2. J Biol Chem 275:8240–8247PubMedCrossRef

11.

Spurlin BA, Park SY, Nevins AK, Kim JK, Thurmond DC (2004) Syntaxin 4 transgenic mice exhibit enhanced insulin-mediated glucose uptake in skeletal muscle. Diabetes 53:2223–2231PubMedCrossRef

12.

Lam PP, Ohno M, Dolai S et al (2013) Munc18b is a major mediator of insulin exocytosis in rat pancreatic beta-cells. Diabetes 62:2416–2428PubMedCrossRef

13.

Oh E, Kalwat MA, Kim MJ, Verhage M, Thurmond DC (2012) Munc18-1 regulates first-phase insulin release by promoting granule docking to multiple syntaxin isoforms. J Biol Chem 287:25821–25833PubMedCentralPubMedCrossRef

14.

Oh E, Thurmond DC (2009) Munc18c depletion selectively impairs the sustained phase of insulin release. Diabetes 58:1165–1174PubMedCentralPubMedCrossRef

15.

Khan AH, Thurmond DC, Yang C, Ceresa BP, Sigmund CD, Pessin JE (2001) Munc18c regulates insulin-stimulated glut4 translocation to the transverse tubules in skeletal muscle. J Biol Chem 276:4063–4069PubMedCrossRef

16.

Tamori Y, Kawanishi M, Niki T et al (1998) Inhibition of insulin-induced GLUT4 translocation by Munc18c through interaction with syntaxin4 in 3 T3-L1 adipocytes. J Biol Chem 273:19740–19746PubMedCrossRef

17.

Thurmond DC, Ceresa BP, Okada S, Elmendorf JS, Coker K, Pessin JE (1998) Regulation of insulin-stimulated GLUT4 translocation by munc18c in 3T3L1 adipocytes. J Biol Chem 273:33876–33883PubMedCrossRef

18.

Tellam JT, Macaulay SL, McIntosh S, Hewish DR, Ward CW, James DE (1997) Characterization of Munc-18c and syntaxin-4 in 3 T3-L1 adipocytes. Putative role in insulin-dependent movement of GLUT-4. J Biol Chem 272:6179–6186PubMedCrossRef

19.

Oh E, Thurmond DC (2006) The stimulus-induced tyrosine phosphorylation of Munc18c facilitates vesicle exocytosis. J Biol Chem 281:17624–17634PubMedCentralPubMedCrossRef

20.

Umahara M, Okada S, Yamada E et al (2008) Tyrosine phosphorylation of Munc18c regulates platelet-derived growth factor-stimulated glucose transporter 4 translocation in 3T3L1 adipocytes. Endocrinology 149:40–49PubMedCrossRef

21.

Jewell JL, Oh E, Ramalingam L et al (2011) Munc18c phosphorylation by the insulin receptor links cell signaling directly to SNARE exocytosis. J Cell Biol 193:185–199PubMedCentralPubMedCrossRef

22.

Bakke J, Bettaieb A, Nagata N, Matsuo K, Haj FG (2013) Regulation of the SNARE-interacting protein Munc18c tyrosine phosphorylation in adipocytes by protein-tyrosine phosphatase 1B. Cell Commun Signal 11:57PubMedCentralPubMedCrossRef

23.

Jewell JL, Oh E, Bennett SM, Meroueh SO, Thurmond DC (2008) The tyrosine phosphorylation of Munc18c induces a switch in binding specificity from syntaxin 4 to Doc2beta. J Biol Chem 283:21734–21746PubMedCentralPubMedCrossRef

24.

Ramalingam L, Oh E, Yoder SM et al (2012) Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. Diabetes 61:2424–2432PubMedCentralPubMedCrossRef

25.

Ke B, Oh E, Thurmond DC (2007) Doc2beta is a novel Munc18c-interacting partner and positive effector of syntaxin 4-mediated exocytosis. J Biol Chem 282:21786–21797PubMedCrossRef

26.

Fukuda N, Emoto M, Nakamori Y et al (2009) DOC2B: a novel syntaxin-4 binding protein mediating insulin-regulated GLUT4 vesicle fusion in adipocytes. Diabetes 58:377–384PubMedCentralPubMedCrossRef

27.

Miyazaki M, Emoto M, Fukuda N et al (2009) DOC2b is a SNARE regulator of glucose-stimulated delayed insulin secretion. Biochem Biophys Res Commun 384:461–465PubMedCrossRef

28.

Yu H, Rathore SS, Davis EM, Ouyang Y, Shen J (2013) Doc2b promotes GLUT4 exocytosis by activating the SNARE-mediated fusion reaction in a calcium- and membrane bending-dependent manner. Mol Biol Cell 24:1176–1184PubMedCentralPubMedCrossRef

29.

Keller MP, Choi Y, Wang P et al (2008) A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res 18:706–716PubMedCentralPubMedCrossRef

30.

Schultze N, Burki Y, Lang Y, Certa U, Bluethmann H (1996) Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol 14:499–503PubMedCrossRef

31.

Spurlin BA, Thomas RM, Nevins AK et al (2003) Insulin resistance in tetracycline-repressible Munc18c transgenic mice. Diabetes 52:1910–1917PubMedCrossRef

32.

Wiseman DA, Kalwat MA, Thurmond DC (2011) Stimulus-induced S-nitrosylation of syntaxin 4 impacts insulin granule exocytosis. J Biol Chem 286:16344–16354PubMedCentralPubMedCrossRef

33.

Stull ND, Breite A, McCarthy R, Tersey SA, Mirmira RG (2012) Mouse islet of Langerhans isolation using a combination of purified collagenase and neutral protease. J Vis Exp 67:e4137

34.

Zhou M, Sevilla L, Vallega G et al (1998) Insulin-dependent protein trafficking in skeletal muscle cells. Am J Physiol 275:E187–E196PubMed

35.

Walker PS, Ramlal T, Sarabia V et al (1990) Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. J Biol Chem 265:1516–1523PubMed

36.

Ferrannini E, Simonson DC, Katz LD et al (1988) The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metab Clin Exp 37:79–85PubMedCrossRef

37.

Edgerton DS, Lautz M, Scott M et al (2006) Insulin’s direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest 116:521–527PubMedCentralPubMedCrossRef

38.

Schmelzle K, Kane S, Gridley S, Lienhard GE, White FM (2006) Temporal dynamics of tyrosine phosphorylation in insulin signaling. Diabetes 55:2171–2179PubMedCrossRef

39.

Groffen AJ, Friedrich R, Brian EC, Ashery U, Verhage M (2006) DOC2A and DOC2B are sensors for neuronal activity with unique calcium-dependent and kinetic properties. J Neurochem 97:818–833PubMedCrossRef

40.

Verhage M, de Vries KJ, Roshol H, Burbach JP, Gispen WH, Sudhof TC (1997) DOC2 proteins in rat brain: complementary distribution and proposed function as vesicular adapter proteins in early stages of secretion. Neuron 18:453–461PubMedCrossRef

41.

Mandic SA, Skelin M, Johansson JU, Rupnik MS, Berggren PO, Bark C (2011) Munc18-1 and Munc18-2 proteins modulate beta-cell Ca2+ sensitivity and kinetics of insulin exocytosis differently. J Biol Chem 286:28026–28040PubMedCentralPubMedCrossRef

Titel: Doc2b enrichment enhances glucose homeostasis in mice via potentiation of insulin secretion and peripheral insulin sensitivity
verfasst von: Latha Ramalingam
Eunjin Oh
Debbie C. Thurmond
Publikationsdatum: 01.07.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Diabetologia / Ausgabe 7/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-014-3227-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2014

Insulin release: the receptor hypothesis

Autoantibodies and type 1 diabetes: are we still in the cave of an ancient myth?

Risk of pancreatitis in patients treated with incretin-based therapies

Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial

Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial